Showing results (271-280 of 365) with videos related to
Sort By:
Pageof 37
Oncotarget|February 22, 2018
Forty five percent of the Israeli population were infected with the influenza B Victoria virus during the winter season 2015-16Sivan Sharabi, Ravit Bassal, Nehemya Friedman, et al.Optics Express|September 13, 2019
Realization of thin-film m-plane InGaN laser diode fabricated by epitaxial lateral overgrowth and mechanical separation from a reusable growth substrateTakeshi Kamikawa, Srinivas Gandrothula, Masahiro Araki, et al.Nature|December 2, 2021
Antiviral activity of bacterial TIR domains via immune signalling moleculesGal Ofir, Ehud Herbst, Maya Baroz, et al.Scientific Reports|November 7, 2015
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's diseaseRodolphe Hajj, Aude Milet, Damien Toulorge, et al.Journal of Lower Genital Tract Disease|August 9, 2014
Prevalence and correlates of human papillomavirus genotypes among patients with cervical cancer and cervical intraepithelial neoplasia 3 in IsraelRavit Bassal, Lia Supino Rosin, Michael Schvimer, et al.United European Gastroenterology Journal|August 8, 2018
Clostridium difficile fecal toxin level is associated with disease severity and prognosisNathaniel A Cohen, Tamar Miller, Wasef Na'aminh, et al.Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society|February 23, 2013
Modeling of the bony pelvis from MRI using a multi-atlas AE-SDM for registration and tracking in image-guided robotic prostatectomyQinquan Gao, Ping-Lin Chang, Daniel Rueckert, et al.Vox Sanguinis|June 14, 2021
Qualifying coronavirus disease 2019 convalescent plasma donors in IsraelMarina Izak, Veronica Gendelman, Sharron Bransburg-Zabary, et al.Antiviral Therapy|April 27, 2016
Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimenStéphane Chevaliez, Jordan Feld, Kevin Cheng, et al.Antimicrobial Agents and Chemotherapy|June 24, 2015
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvirPreethi Krishnan, Rakesh Tripathi, Gretja Schnell, et al.Pageof 37